These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 2014965)

  • 41. In vitro activity of netilmicin compared with gentamicin, tobramycin, amikacin, and kanamycin.
    Eickhoff TC; Ehret JM
    Antimicrob Agents Chemother; 1977 May; 11(5):791-6. PubMed ID: 879733
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Influence of aminoglycoside usage on susceptibilities.
    Flournoy DJ
    Chemotherapy; 1985; 31(3):178-80. PubMed ID: 3922684
    [TBL] [Abstract][Full Text] [Related]  

  • 43. The effect of dosing strategy on kidney cortical accumulation of aminoglycosides in rats.
    Giuliano RA; Verpooten GA; De Broe ME
    Am J Kidney Dis; 1986 Nov; 8(5):297-303. PubMed ID: 3788968
    [TBL] [Abstract][Full Text] [Related]  

  • 44. In vitro activity of gentamicin, amikacin and netilmicin alone and in combination with carbenicillin against Serratia marcescens.
    Pogwizd SM; Lerner SA
    Antimicrob Agents Chemother; 1976 Dec; 10(6):878-84. PubMed ID: 795373
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Susceptibility of current clinical isolates of Pseudomonas aeruginosa and enteric gram-negative bacilli to amikacin and other aminoglycoside antibiotics.
    Dámaso D; Moreno-López M; Martínez-Beltrán J; García-Iglesias MC
    J Infect Dis; 1976 Nov; 134 SUPPL():S394-90. PubMed ID: 825591
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Serum bactericidal activity and postantibiotic effect in serum of patients with urinary tract infection receiving high-dose amikacin.
    Van der Auwera P; Klastersky J
    Antimicrob Agents Chemother; 1987 Jul; 31(7):1061-8. PubMed ID: 3116918
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Bactericidal activities of teicoplanin, vancomycin, and gentamicin alone and in combination against Staphylococcus aureus in an in vitro pharmacodynamic model of endocarditis.
    McGrath BJ; Kang SL; Kaatz GW; Rybak MJ
    Antimicrob Agents Chemother; 1994 Sep; 38(9):2034-40. PubMed ID: 7811015
    [TBL] [Abstract][Full Text] [Related]  

  • 48. The comparative synergistic activity of amikacin, gentamicin, netilmicin and azlocillin, mezlocillin, carbenicillin and ticarcillin against Serratia marcescens.
    Fu KP; Neu HC
    J Antibiot (Tokyo); 1978 Feb; 31(2):135-40. PubMed ID: 344298
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Tobramycin, amikacin, sissomicin, and gentamicin resistant Gram-negative rods.
    Drasar FA; Farrell W; Maskell J; Williams JD
    Br Med J; 1976 Nov; 2(6047):1284-7. PubMed ID: 1000196
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Aminoglycosides plus beta-lactams against gram-negative organisms. Evaluation of in vitro synergy and chemical interactions.
    Giamarellou H
    Am J Med; 1986 Jun; 80(6B):126-37. PubMed ID: 3088998
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Comparative efficacies of liposomal amikacin (MiKasome) plus oxacillin versus conventional amikacin plus oxacillin in experimental endocarditis induced by Staphylococcus aureus: microbiological and echocardiographic analyses.
    Xiong YQ; Kupferwasser LI; Zack PM; Bayer AS
    Antimicrob Agents Chemother; 1999 Jul; 43(7):1737-42. PubMed ID: 10390232
    [TBL] [Abstract][Full Text] [Related]  

  • 52.
    Fleischmann WA; Greenwood-Quaintance KE; Patel R
    Antimicrob Agents Chemother; 2020 Jan; 64(2):. PubMed ID: 31712206
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Antibacterial activity of amikacin towards gentamicin-resistant, Gram-negative bacilli].
    Nicoletti G; Russo G; Toscano MA; Gismondo MR
    Boll Ist Sieroter Milan; 1979 Jan; 57(6):713-7. PubMed ID: 121911
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Optimal aminoglycoside dosing regimen for penicillin-tobramycin synergism in experimental Streptococcus adjacens endocarditis.
    Saleh-Mghir A; Cremieux AC; Vallois JM; Muffat-Joly M; Devine C; Carbon C
    Antimicrob Agents Chemother; 1992 Nov; 36(11):2403-7. PubMed ID: 1489184
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Antimicrobial activity of netilmicin in comparison with gentamicin, sisomicin, tobramycin, and amikacin and their resistance patterns.
    Braveny I; Voeckl J; Machka K
    Arzneimittelforschung; 1980; 30(3):491-5. PubMed ID: 7387761
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Surveillance of aminoglycoside resistance. European data.
    Van Landuyt HW; Boelaert J; Glibert B; Gordts B; Verbruggen AM
    Am J Med; 1986 Jun; 80(6B):76-81. PubMed ID: 3089007
    [TBL] [Abstract][Full Text] [Related]  

  • 57. In vitro study of netilmicin compared with other aminoglycosides.
    Fu KP; Neu HC
    Antimicrob Agents Chemother; 1976 Sep; 10(3):526-34. PubMed ID: 10829
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Analysis of neomycin, kanamycin, tobramycin and amikacin resistance mechanisms in gentamicin-resistant isolates of Enterobacteriaceae.
    Adwan K; Abu-Hasan N; Al-Asmar H
    J Med Microbiol; 1998 Nov; 47(11):1019-21. PubMed ID: 9822302
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Antimicrobial susceptibility of clinical isolates of Serratia marcescens.
    Alvarez JS; Regueiro B; Garrido MJ
    Antimicrob Agents Chemother; 1979 Oct; 16(4):523-4. PubMed ID: 391150
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Comparative in vitro activity of netilmicin, amikacin, tobramycin and sisomicin against gentamicin highly-resistant enterobacteriaceae.
    Tselentis J; Legakis NJ; Nicolas KJ; Melissinos K; Papavassiliou J
    Chemotherapy; 1980; 26(6):409-17. PubMed ID: 7408554
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.